Legend Biotech (NASDAQ: LEGN) reported Q1 EPS of ($0.16), $0.03 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $93.99 million versus the consensus estimate of $143.81 million.

For earnings history and earnings-related data on Legend Biotech (LEGN) click here.